The American College of Physicians is calling for major changes to dietary supplement regulation. NPA and CRN respond with different perspectives.

CRN's Supreme Court challenge, Texas' protein powder investigation, DEA's action on synthetic 7-OH, and New Hampshire's herbal tincture victory highlight the latest regulatory developments shaping the dietary supplement and natural products industry.

From microbiome-targeted solutions to omega fatty acids, NAD+ preservation, and plant-based proteins, a wave of new clinical and peer-reviewed research is reshaping how functional ingredients are studied, positioned, and applied across gut, metabolic, cardiovascular, and healthy aging categories.

From metabolic health to cognitive support and gut wellness, the latest research offers fresh insights into ingredient innovation across the nutraceutical industry.

Natural products industry companies share overviews on the latest research on their dietary supplement branded ingredients and formulations to support overall health and well-being.

Natural products industry companies share overviews on the latest research on their dietary supplement branded ingredients and formulations to support overall health and well-being.

NOW Foods evaluated 28 lavender essential oil products purchased on Amazon using GC-MS/FID testing and reported that only three met ISO standards for authentic Lavandula angustifolia oil without evidence of adulteration.

Bipartisan legislation introduced in Congress would expand access to dietary supplements by allowing eligible products to be purchased through HSAs, FSAs, and HRAs, a move supporters say better aligns federal policy with preventive health practices.

Following petitions arguing the ban of ashwagandha leaves or extracts that contain leaf in health supplements bypassed formal regulatory amendment procedures under existing food safety frameworks, The Karnataka High Court has issued an interim stay and scheduled a follow-up hearing.

NPA members brought key supplement policy priorities directly to lawmakers, including concerns over state-level restrictions and mandatory product listing proposals.